Search trials



Primary RegistryProtocol numberPublic titleScientific titleType of studyRecruitment statusLast updated
LBCTR2021034768CUER132020In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2InterventionalComplete07/03/2021
LBCTR2021064778232SM203Study of Nusinersen (BIIB058) in Participants With Spinal Muscular AtrophyEscalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular AtrophyInterventionalPending28/06/2021
LBCTR2021044780CUER342021Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19InterventionalPending27/03/2021
LBCTR2021064783VIT-2763-SCD-202A Phase 2a study to assess efficacy and safety of VIT-2763 in subjects with sickle cell diseaseA Phase 2a, double-blind, randomised, placebo-controlled, ascending dose and maintenance dose, efficacy, and safety study of multiple doses of VIT-2763 in subjects with sickle cell diseaseInterventionalPending24/06/2021
LBCTR2020030215MS700568_0026Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Tablets for Multiple SclerosisAn Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical TrialsObservationalComplete11/06/2021
LBCTR2021054816CEHDF 1787Effects of different mental training techniques on fine motor performance.Comparison between the effects of Neurofeedback training and Motor imagery training on motor performance in a finger tapping task.InterventionalRecruiting16/06/2021
LBCTR2019060201CPDR001X2101Phase I/II Study of PDR001 in Patients With Advanced Malignancies Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001 Administered to Patients With Advanced MalignanciesInterventionalComplete20/02/2019
LBCTR2021074838GBT2104-133An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical TrialAn Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical TrialInterventionalPending05/07/2021
LBCTR2022024840ISRCTN52076264Supporting Mothers’ Mental Health with Interpersonal TherapyEvaluating the impact of group interpersonal psychotherapy compared to high-quality standard care for mothers with postnatal depression in Lebanon and Kenya on child developmental outcomes, maternal depression and the mother-child relationshipInterventionalPending13/07/2021
LBCTR2019020189CICL670FIC05Open-label, Multicenter, Single Arm, Phase II Study Assessing Treatment Patient Preference for New Deferasirox Formulation (Film-coated Tablet) Compared to the Reference Deferasirox Dispersible Tablet FormulationOpen-label, Multicenter, Single Arm, Phase II Study Assessing Treatment Patient Preference for New Deferasirox Formulation (Film-coated Tablet) Compared to the Reference Deferasirox Dispersible Tablet FormulationInterventionalComplete06/02/2019
items per page51 - 60 of 169 items